NYSE - Delayed Quote USD
Abbott Laboratories (ABT)
133.58
-0.36
(-0.27%)
At close: June 6 at 4:00:02 PM EDT
133.03
-0.55
(-0.41%)
After hours: June 6 at 6:51:05 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 21 | 21 | 26 | 26 |
| Avg. Estimate | 1.25 | 1.34 | 5.16 | 5.68 |
| Low Estimate | 1.14 | 1.21 | 5.08 | 5.56 |
| High Estimate | 1.3 | 1.4 | 5.24 | 5.82 |
| Year Ago EPS | 1.14 | 1.21 | 4.67 | 5.16 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 21 | 21 | 26 | 26 |
| Avg. Estimate | 11.01B | 11.36B | 44.63B | 48.02B |
| Low Estimate | 10.38B | 10.63B | 44.1B | 47.05B |
| High Estimate | 11.13B | 11.62B | 45.1B | 49.07B |
| Year Ago Sales | 10.38B | 10.63B | 41.95B | 44.63B |
| Sales Growth (year/est) | 6.09% | 6.79% | 6.39% | 7.60% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | 1.1 | 1.2 | 1.34 | 1.07 |
| EPS Actual | 1.14 | 1.21 | 1.34 | 1.09 |
| Difference | 0.04 | 0.01 | -0 | 0.02 |
| Surprise % | 3.17% | 0.76% | -0.17% | 1.74% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 1.25 | 1.34 | 5.16 | 5.68 |
| 7 Days Ago | 1.25 | 1.33 | 5.15 | 5.67 |
| 30 Days Ago | 1.25 | 1.33 | 5.15 | 5.67 |
| 60 Days Ago | 1.25 | 1.35 | 5.15 | 5.7 |
| 90 Days Ago | 1.24 | 1.34 | 5.15 | 5.67 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 7 | 7 | 2 | 1 |
| Up Last 30 Days | 6 | 5 | 9 | 9 |
| Down Last 7 Days | 7 | 8 | -- | 1 |
| Down Last 30 Days | 8 | 9 | 4 | 13 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| ABT | 9.51% | 10.44% | 10.42% | 10.08% |
| S&P 500 | 13.13% | 2.48% | 7.55% | 14.01% |
Upgrades & Downgrades
| Maintains | Raymond James: Outperform to Outperform | 4/17/2025 |
| Reiterates | Piper Sandler: Overweight to Overweight | 4/17/2025 |
| Maintains | RBC Capital: Outperform to Outperform | 4/17/2025 |
| Maintains | Wells Fargo: Overweight to Overweight | 4/17/2025 |
| Maintains | Morgan Stanley: Equal-Weight to Equal-Weight | 4/17/2025 |
| Maintains | Barclays: Overweight to Overweight | 4/17/2025 |
Related Tickers
MDT Medtronic plc
87.44
+0.51%
BSX Boston Scientific Corporation
102.09
-0.72%
SYK Stryker Corporation
383.89
+0.21%
DXCM DexCom, Inc.
86.67
+1.08%
EW Edwards Lifesciences Corporation
77.52
-0.32%
PODD Insulet Corporation
311.77
-1.70%
SENS Senseonics Holdings, Inc.
0.5269
-0.26%
TMDX TransMedics Group, Inc.
139.05
+2.55%
INSP Inspire Medical Systems, Inc.
136.02
+0.11%
ZBH Zimmer Biomet Holdings, Inc.
92.38
+0.50%